|
PUT
|
$208,000
|
13.4K
|
Q3 2024
Reduced 22.81%
|
|
|
PUT
|
$292,000
|
6.8K
|
Q3 2024
New holding
|
|
|
PUT
|
$530,000
|
50.2K
|
Q2 2024
Reduced 42.69%
|
|
|
CALL
|
$395,000
|
6K
|
Q2 2024
New holding
|
|
|
CALL
|
$336,000
|
63.8K
|
Q3 2024
New holding
|
|
|
PUT
|
$224,000
|
158K
|
Q2 2024
New holding
|
|
|
CALL
|
$460,000
|
129K
|
Q3 2024
New holding
|
|
|
PUT
|
$415,000
|
47.8K
|
Q3 2024
Added 127.62%
|
|
|
PUT
|
$249,000
|
6.5K
|
Q3 2024
New holding
|
|
|
CALL
|
$207,000
|
44.4K
|
Q1 2024
New holding
|
|
|
PUT
|
$411,000
|
3.6K
|
Q3 2024
New holding
|
|
|
PUT
|
$496,000
|
12.5K
|
Q3 2024
New holding
|
|
|
PUT
|
$237,000
|
9.1K
|
Q3 2024
New holding
|
|
|
PUT
|
$192,000
|
41.1K
|
Q3 2024
New holding
|
|
|
CALL
|
$363,000
|
99.1K
|
Q2 2024
New holding
|
|
|
PUT
|
$390,000
|
800
|
Q3 2024
Reduced 95.45%
|
|
|
PUT
|
$333,000
|
78.4K
|
Q2 2024
Reduced 4.62%
|
|
|
CALL
|
$363,000
|
44K
|
Q3 2024
Reduced 50.39%
|
|
|
CALL
|
$452,000
|
2.2K
|
Q3 2024
New holding
|
|
|
CALL
|
$480,000
|
26K
|
Q3 2024
New holding
|
|
|
CALL
|
$354,000
|
26K
|
Q3 2024
Reduced 49.22%
|
|
|
PUT
|
$156,000
|
15.5K
|
Q3 2024
New holding
|
|
Corbus Pharmaceuticals Hldgs
|
CALL
|
$0
|
32.2K
|
Q3 2024
New holding
|
|
Neumora Therapeutics Inc.
|
PUT
|
$0
|
117K
|
Q3 2024
New holding
|
|
Perspective Therapeutics Inc
|
PUT
|
$0
|
22.4K
|
Q3 2024
New holding
|
|
|
PUT
|
$166,000
|
50K
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
95.1K
|
Q3 2024
New holding
|
|
Ginkgo Bioworks Holdings Inc
|
PUT
|
$0
|
17.6K
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
119K
|
Q3 2024
New holding
|
|
Corbus Pharmaceuticals Hldgs
|
PUT
|
$0
|
71.9K
|
Q3 2024
New holding
|
|
|
PUT
|
$53,000
|
21.7K
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
18.2K
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
59.2K
|
Q3 2024
New holding
|
|
|
PUT
|
$0
|
41.2K
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
103K
|
Q3 2024
New holding
|
|
|
CALL
|
$53,000
|
104K
|
Q2 2024
New holding
|
|
|
CALL
|
$0
|
126K
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
32.1K
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
89.6K
|
Q3 2024
New holding
|
|
|
CALL
|
$112,000
|
13K
|
Q3 2024
Added 127.62%
|
|
|
PUT
|
$0
|
132K
|
Q3 2024
New holding
|
|
|
CALL
|
$155,000
|
31.5K
|
Q3 2024
Reduced 92.85%
|
|
|
CALL
|
$0
|
26K
|
Q3 2024
New holding
|
|
|
CALL
|
$0
|
30K
|
Q3 2024
Added 100.0%
|
|
|
PUT
|
$0
|
68.6K
|
Q3 2024
Added 87.43%
|
|
Neumora Therapeutics Inc.
|
CALL
|
$0
|
117K
|
Q3 2024
New holding
|
|